Skip to main content

Aspira Women's Health Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

AWHL$0.430.0%Stored close · as of Sep 19, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​​Page
PART IFinancial Information1
Item 1Financial Statements (unaudited)1
​Condensed Consolidated Balance Sheets as of June 30, 2026 and December 31, 20251
​Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 and 20252
​Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three and six months ended June 30, 2026 and 20253
​Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2026 and 20255
​Notes to Condensed Consolidated Financial Statements6
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations28
Item 3Quantitative and Qualitative Disclosures About Market Risk41
Item 4Controls and Procedures42
PART IIOther Information43
Item 1Legal Proceedings43
Item 1ARisk Factors43
Item 2Unregistered Sales of Equity Securities and Use of Proceeds43
Item 3Defaults Upon Senior Securities43
Item 4Mine Safety Disclosures43
Item 5Other Information43
Item 6Exhibits44
SIGNATURES45

The following are registered and unregistered trademarks and service marks of Aspira Women’s Health Inc.: VERMILLIONSM*, ASPIRA WOMEN’S HEALTH*®, OVA1®, OVERA®, ASPIRA LABS®, OVACALC®, OVASUITESM*, ASPIRA GENETIXSM, OVA1PLUS*®, OVAWATCH®, ENDOCHECKSM*, ENDOINFORMTM, OVAINFORMTM, OVAINHERITSM, ASPIRA SYNERGY*®, OVA360SM*, ASPIRA IVDSM, AND YOUR HEALTH, OUR PASSION*®.

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.